首页|期刊导航|中国实用外科杂志|示踪用盐酸米托蒽醌在甲状腺乳头状癌术中应用研究

示踪用盐酸米托蒽醌在甲状腺乳头状癌术中应用研究OA北大核心CSTPCD

Effect of mitoxantrone hydrochloride injection for tracing in thyroidectomy for papillary thyroid cancer

中文摘要英文摘要

目的 探讨盐酸米托蒽醌与纳米碳注射液在甲状腺乳头状癌术中对甲状旁腺保护及淋巴结示踪效果的差异性,并研究盐酸米托蒽醌注射的最佳时间.方法 前瞻性分析2023年1月至2023年7月哈尔滨医科大学附属第二医院甲状腺外科行单侧甲状腺癌根治术病人的临床资料,观察示踪剂腺体注射后和不同注射时间点注射后的染色满意度、淋巴结示踪效果、甲状旁腺辨识情况、原位保留情况、意外切除情况、自体移植情况、喉返神经损伤情况、手术时长及术后甲状旁腺激素(PTH)和血钙情况.结果 试验一:盐酸米托蒽醌组染色满意度评分较纳米碳组差异无统计学意义(P=0.341),米托蒽醌组的被膜染色例数显著少于纳米碳组(5例vs.13例,P<0.05),且米托蒽醌组的气管食管沟染色例数(4例)较纳米碳组(10例)有减少趋势(P=0.067).米托蒽醌组术中甲状旁腺检出量及原位保留量分别为(1.80±0.41)枚、(1.66±0.48)枚,纳米碳组为(1.73±0.45)枚、(1.57±0.50)枚,显著高于对照组(1.37±0.49)枚、(1.20±0.41)枚,差异有统计学意义(P<0.05).试验二:米托蒽醌术前2h和术中注射组的甲状旁腺检出量和原位保留量分别为(1.70±0.47)枚、(1.57±0.50)枚,(1.73±0.45)枚、(1.60±0.50)枚,显著高于术前24h注射组(1.37±0.49)枚、(1.20±0.41)枚,差异有统计学意义(P<0.05).术中注射组的手术时间为(46.77±9.71)min,与术前2 h组的(42.10±11.03)min和术前24h组(41.73±10.42)min相比增加(P=0.064、P=0.086).结论 盐酸米托蒽醌与纳米碳相比具有更好的术区清晰度,有更好的显露并保护喉返神经的潜力,且术前2 h为示踪用盐酸米托蒽醌注射的最佳时间.

Objective To explore the difference in parathyroid protection and lymph node tracing effects between mitoxantrone hydrochloride and nanocarbon injection during papillary thyroid cancer(PTC)surgery,and to study the optimal time for mitoxantrone hydrochloride injection.Methods Prospectively analyze the clinical data of patients who underwent unilateral radical resection for thyroid cancer in the Thyroid Surgery Department of the Second Affiliated Hospital of Harbin Medical University from January 2023 to July 2023,observe the staining satisfaction,lymph node tracing effect,parathyroid gland identification,in-situ retention,miscutting,autologous transplantation,and recurrent laryngeal nerve injury after tracer gland injection and injection at different injection time points,operation duration and postoperative PTH and serum calcium status.Results Experiment 1:There was no significant difference in the staining satisfaction score of the mitoxantrone hydrochloride group compared with the nanocarbon group(P=0.341),the number of cases of membrane staining in the mitoxantrone group was significantly lower than that in the nanocarbon group(5 cases vs.13 cases)(P<0.05),and the number of cases of tracheoesophageal groove staining in the mitoxantrone group(4 cases)was lower than that in the nanocarbon group(10 cases)(P=0.067).The intraoperative detection amount and in-situ retention amount of parathyroid glands in the mitoxantrone group(1.80±0.41),(1.66±0.48)and the nanocarbon group(1.73±0.45),(1.57±0.50)were significantly higher than those in the control group(1.37±0.49),(1.20±0.41),with statistical differences(P<0.05).Experiment 2:The amount of parathyroid glands detected and retained in situ in the mitoxantrone injection group 2 hours before surgery and intraoperatively were(1.70±0.47),(1.57±0.50),(1.73±0.45),(1.60±0.50)respectively were significantly higher than those in the injection group 24 hours before surgery(1.37±0.49),(1.20±0.41),and the difference was statistically significant(P<0.05).The operation time of the intraoperative injection group was(46.77±9.71)min,which showed an increasing trend compared with(42.10±1 1.03)min of the 2 h preoperative group and(41.73±10.42)min of the 24 h preoperative group(P=0.064,P=0.086).Conclusion Compared with nanocarbon,mitoxantrone hydrochloride has a better definition of the surgical area and has better potential to expose and protect the recurrent laryngeal nerve.The best time for tracer mitoxantrone hydrochloride injection is 2 hours before surgery.

陶星儒;石臣磊;石铁锋;吴罡;刘英明;董加宇

哈尔滨医科大学附属第二临床医院普外四科,黑龙江哈尔滨 150086

临床医学

甲状腺乳头状癌示踪用盐酸米托蒽醌注射液纳米碳注射液甲状旁腺

papillary thyroid cancermitoxantrone hydrochloride injection fortracingnanocarbon injectionparathyroid gland

《中国实用外科杂志》 2024 (006)

685-691 / 7

黑龙江自然科学基金面上项目(No.2017005);哈尔滨医科大学横向协作课题项目(No.20220701)

10.19538/j.cjps.issn1005-2208.2024.06.16

评论